LINK WILLIAM J PHD

CIK 000122868414 companiesIRVINE, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001228684

Recent Transactions

50 trades

Award
Tarsus Pharmaceuticals, Inc.$TARS
Stock Option (right to buy)
2026-06-25+3,837→ 3,837 total
Award
Tarsus Pharmaceuticals, Inc.$TARS
Restricted Stock Units
2026-06-25+2,417→ 2,417 total
Award
Tarsus Pharmaceuticals, Inc.$TARS
Restricted Stock Units
2026-06-25+806→ 806 total
Award
RxSight, Inc.$RXST
Common Stock
2026-06-17+37,037→ 74,892 total
Sale
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2026-06-15$61.97/sh−10,572→ 108,714 total
Sale
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2026-06-15$62.94/sh−1,928→ 106,786 total
Exercise/Conversion
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2026-06-12+2,954→ 119,286 total
Exercise/Conversion
Tarsus Pharmaceuticals, Inc.$TARS
Restricted Stock Units
2026-06-12−2,954→ 0 total
Award
LENSAR, Inc.$LNSR
Common Stock
2026-06-03+17,421→ 568,062 total
Sale
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2026-03-16$69.75/sh−493→ 116,332 total
Sale
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2026-03-16$68.09/sh−3,629→ 125,203 total
Sale
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2026-03-16$69.03/sh−8,378→ 116,825 total
Sale
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2025-12-15$81.50/sh−4,766→ 0 total
Sale
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2025-12-15$80.71/sh−5,680→ 4,766 total
Sale
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2025-12-15$82.39/sh−1,148→ 128,832 total
Sale
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2025-12-15$80.80/sh−5,046→ 136,286 total
Sale
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2025-12-15$81.75/sh−6,306→ 129,980 total
Gift
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2025-09-16−2,000→ 141,332 total
Sale
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2025-09-08$57.00/sh−27,116→ 143,332 total
Exercise/Conversion
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2025-06-13+3,350→ 170,448 total
Exercise/Conversion
Tarsus Pharmaceuticals, Inc.$TARS
Restricted Stock Units
2025-06-13−3,350→ 0 total
Award
Tarsus Pharmaceuticals, Inc.$TARS
Stock Option (right to buy)
2025-06-12+4,540→ 4,540 total
Award
Tarsus Pharmaceuticals, Inc.$TARS
Restricted Stock Units
2025-06-12+2,954→ 2,954 total
Award
RxSight, Inc.$RXST
Common Stock
2025-06-03+10,752→ 37,855 total
Award
LENSAR, Inc.$LNSR
Common Stock
2025-05-23+7,374→ 550,641 total
Other
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2024-08-12−74,892→ 35,000 total
Sale
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2024-08-12$26.01/sh−29,979→ 5,021 total
Other
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2024-08-12+27,116→ 167,098 total
Other
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2024-08-12+10,446→ 10,446 total
Sale
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2024-08-12$26.53/sh−5,021→ 0 total
Exercise/Conversion
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2024-06-24+3,350→ 139,982 total
Exercise/Conversion
Tarsus Pharmaceuticals, Inc.$TARS
Restricted Stock Units
2024-06-24−3,350→ 0 total
Award
Tarsus Pharmaceuticals, Inc.$TARS
Restricted Stock Units
2024-06-13+3,350→ 3,350 total
Award
Tarsus Pharmaceuticals, Inc.$TARS
Stock Option (right to buy)
2024-06-13+5,000→ 5,000 total
Award
RxSight, Inc.$RXST
Common Stock
2024-06-06+2,554→ 27,103 total
Award
LENSAR, Inc.$LNSR
Common Stock
2024-05-07+22,000→ 543,267 total
Sale
RxSight, Inc.$RXST
Common Stock
2024-02-01$50.01/sh−7,652→ 24,248 total
Sale
RxSight, Inc.$RXST
Common Stock
2024-02-01$49.54/sh−20,598→ 31,900 total
Gift
RxSight, Inc.$RXST
Common Stock
2024-02-01−3,000→ 21,248 total
Other
RxSight, Inc.$RXST
Common Stock
2023-08-17+21,248→ 52,498 total
Other
RxSight, Inc.$RXST
Common Stock
2023-08-17+2,610→ 24,549 total
Other
RxSight, Inc.$RXST
Common Stock
2023-08-17−694,124→ 0 total
Award
Tarsus Pharmaceuticals, Inc.$TARS
Restricted Stock Units
2023-06-22+3,350→ 3,350 total
Award
Tarsus Pharmaceuticals, Inc.$TARS
Stock Option (right to buy)
2023-06-22+5,000→ 5,000 total
Exercise/Conversion
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2023-06-16+2,000→ 136,632 total
Exercise/Conversion
Tarsus Pharmaceuticals, Inc.$TARS
Restricted Stock Units
2023-06-16−2,000→ 0 total
Award
RxSight, Inc.$RXST
Common Stock
2023-06-01+5,731→ 21,939 total
Award
LENSAR, Inc.$LNSR
Stock Option (Right to Buy)
2023-05-25+33,175→ 33,175 total
Award
LENSAR, Inc.$LNSR
Common Stock
2023-05-25+9,288→ 521,267 total
Other
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2023-05-11+41,219→ 109,892 total

Companies

Recent Filings

Address

C/O TARSUS PHARMACEUTICALS, INC. 17700 LAGUNA CANYON ROAD, FLOOR 4

IRVINE, CA, 92618

View on SEC.gov